Deutsche Bank Ag\ Cerus Corp Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Cerus Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 94,420 shares of CERS stock, worth $186,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,420

Previous 61,709 53.01%

Holding current value

$186,007

Previous $108,000 51.85%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.7 - $2.39 $55,608 - $78,179	32,711 Added 53.01%	94,420 $164,000
Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.04 $32,406 - $40,808	-20,004 Reduced 24.48%	61,709 $108,000
Q1 2024 May 15, 2024	BUY	$1.66 - $2.42 $10,227 - $14,909	6,161 Added 8.15%	81,713 $154,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.35 $3,527 - $6,631	-2,822 Reduced 3.6%	75,552 $163,000
Q3 2023 Nov 09, 2023	BUY	$1.5 - $3.07 $23,172 - $47,425	15,448 Added 24.55%	78,374 $126,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $86,233 - $139,707	-48,175 Reduced 43.36%	62,926 $154,000
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $18,340 - $26,369	6,921 Added 6.64%	111,101 $329,000
Q4 2022 Feb 13, 2023	BUY	$3.38 - $4.22 $42,591 - $53,176	12,601 Added 13.76%	104,180 $380,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $183,395 - $311,718	-53,468 Reduced 36.86%	91,579 $330,000
Q2 2022 Aug 11, 2022	SELL	$4.41 - $5.69 $50,891 - $65,662	-11,540 Reduced 7.37%	145,047 $768,000
Q1 2022 May 13, 2022	SELL	$4.81 - $6.99 $50,129 - $72,849	-10,422 Reduced 6.24%	156,587 $860,000
Q4 2021 Feb 11, 2022	BUY	$5.97 - $7.93 $15,074 - $20,023	2,525 Added 1.54%	167,009 $1.14 Million
Q3 2021 Nov 04, 2021	SELL	$4.79 - $6.68 $14,901 - $20,781	-3,111 Reduced 1.86%	164,484 $1 Million
Q2 2021 Aug 11, 2021	SELL	$5.35 - $6.35 $28,606 - $33,953	-5,347 Reduced 3.09%	167,595 $990,000
Q1 2021 May 13, 2021	SELL	$5.68 - $7.87 $61,520 - $85,239	-10,831 Reduced 5.89%	172,942 $1.04 Million
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $172,047 - $280,519	32,771 Added 21.7%	183,773 $1.27 Million
Q3 2020 Nov 12, 2020	SELL	$5.78 - $7.47 $733,094 - $947,442	-126,833 Reduced 45.65%	151,002 $945,000
Q2 2020 Aug 13, 2020	BUY	$4.5 - $7.02 $788,499 - $1.23 Million	175,222 Added 170.76%	277,835 $1.83 Million
Q1 2020 May 14, 2020	SELL	$2.87 - $5.49 $14,008 - $26,796	-4,881 Reduced 4.54%	102,613 $477,000
Q4 2019 Feb 14, 2020	SELL	$3.84 - $4.86 $250,352 - $316,852	-65,196 Reduced 37.75%	107,494 $452,000
Q3 2019 Nov 14, 2019	SELL	$4.86 - $6.05 $99,838 - $124,285	-20,543 Reduced 10.63%	172,690 $889,000
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $1.28 Million - $1.88 Million	-284,166 Reduced 59.52%	193,233 $1.08 Million
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $1.55 Million - $2.06 Million	300,288 Added 169.55%	477,399 $2.97 Million
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $963,765 - $1.41 Million	-197,089 Reduced 52.67%	177,111 $895,000
Q3 2018 Dec 21, 2021	BUY	$6.89 - $7.78 $610,660 - $689,541	88,630 Added 31.04%	374,200 $2.7 Million
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $1.24 Million - $1.4 Million	-180,567 Reduced 38.74%	285,570 $2.06 Million
Q2 2018 Apr 21, 2020	BUY	$5.19 - $7.25 $513,612 - $717,474	98,962 Added 26.95%	466,137 $3.11 Million
Q2 2018 Aug 14, 2018	BUY	$5.19 - $7.25 $42,236 - $59,000	8,138 Added 2.27%	367,175 $2.45 Million
Q1 2018 Oct 18, 2019	BUY	$3.56 - $5.74 $319,353 - $514,912	89,706 Added 33.31%	359,037 $1.97 Million
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $8,116 - $13,087	2,280 Added 0.85%	269,331 $1.47 Million
Q4 2017 Feb 14, 2018	SELL	$2.76 - $3.95 $3.79 Million - $5.43 Million	-1,374,980 Reduced 83.74%	267,051 $900,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $3.65 Million - $4.48 Million	1,642,031	1,642,031 $4.48 Million

Others Institutions Holding CERS

# of Institutions

157

Shares Held

148M

Call Options Held

84.2K

Put Options Held

55.5K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $349M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account